OGEN
Price
$0.20
Change
+$0.01 (+5.26%)
Updated
Apr 25, 04:52 PM (EDT)
Capitalization
4.17M
RNA
Price
$30.87
Change
-$0.06 (-0.19%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
3.72B
18 days until earnings call
Ad is loading...

OGEN vs RNA

Header iconOGEN vs RNA Comparison
Open Charts OGEN vs RNABanner chart's image
Oragenics
Price$0.20
Change+$0.01 (+5.26%)
Volume$307
Capitalization4.17M
Avidity Biosciences
Price$30.87
Change-$0.06 (-0.19%)
Volume$17.74K
Capitalization3.72B
OGEN vs RNA Comparison Chart
Loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGEN vs. RNA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGEN is a Hold and RNA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (OGEN: $0.19 vs. RNA: $30.93)
Brand notoriety: OGEN and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OGEN: 51% vs. RNA: 72%
Market capitalization -- OGEN: $4.17M vs. RNA: $3.72B
OGEN [@Biotechnology] is valued at $4.17M. RNA’s [@Biotechnology] market capitalization is $3.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGEN’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • OGEN’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than OGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGEN’s TA Score shows that 6 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • OGEN’s TA Score: 6 bullish, 2 bearish.
  • RNA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OGEN is a better buy in the short-term than RNA.

Price Growth

OGEN (@Biotechnology) experienced а +10.91% price change this week, while RNA (@Biotechnology) price change was +16.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

OGEN is expected to report earnings on Mar 14, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.72B) has a higher market cap than OGEN($4.17M). RNA YTD gains are higher at: 6.362 vs. OGEN (-47.441). OGEN has higher annual earnings (EBITDA): -19.94M vs. RNA (-376.16M). RNA has more cash in the bank: 1.5B vs. OGEN (3.14M). OGEN has less debt than RNA: OGEN (519K) vs RNA (6.8M). RNA has higher revenues than OGEN: RNA (10.9M) vs OGEN (0).
OGENRNAOGEN / RNA
Capitalization4.17M3.72B0%
EBITDA-19.94M-376.16M5%
Gain YTD-47.4416.362-746%
P/E RatioN/AN/A-
Revenue010.9M-
Total Cash3.14M1.5B0%
Total Debt519K6.8M8%
FUNDAMENTALS RATINGS
OGEN: Fundamental Ratings
OGEN
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGENRNA
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQQ15.100.55
+3.78%
Arqit Quantum Inc
GSAT19.550.45
+2.36%
Globalstar Inc
EVRG68.280.17
+0.25%
Evergy
ATNF0.86N/A
-0.13%
180 Life Sciences Corp
TRTX7.27-0.05
-0.68%
TPG RE Finance Trust

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
+0.05%
ATHA - OGEN
37%
Loosely correlated
+5.63%
SRPT - OGEN
30%
Poorly correlated
+3.82%
CHRS - OGEN
27%
Poorly correlated
-9.01%
ADMA - OGEN
26%
Poorly correlated
+2.76%
RNA - OGEN
26%
Poorly correlated
+0.81%
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with ACLX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
+0.81%
ACLX - RNA
52%
Loosely correlated
+0.53%
STOK - RNA
49%
Loosely correlated
+3.78%
DYN - RNA
48%
Loosely correlated
+3.06%
CRNX - RNA
47%
Loosely correlated
+3.15%
ROIV - RNA
46%
Loosely correlated
+2.42%
More